Education
PhD, Epidemiology, NYU Grossman School of MedicineMPA, Public Policy, New York University
BA, Comparative Literature, New York University
Research Interests
Overdose, drug policy, policing, public health ethics, social determinants of health, harm reduction BIO
Bennett Allen is an Assistant Professor at the Center for Opioid Epidemiology and Policy, Department of Population Health. His research uses epidemiologic, econometric, and machine learning methods to evaluate supply-side strategies to reduce overdose death. Additional work engages bioethics in relation to public health policy. Current projects examine the impact of drug-induced homicide laws and prosecutions on opioid overdose mortality, the role of prescription drug monitoring programs in pain management cessation, spatiotemporal prediction of overdose mortality risk, and the ethical uses of big data in public health practice. Prior to joining NYU, he worked in drug policy for the New York City government. Projects
Principal Investigator, Assessing the Impact of Overdose Prevention Centers as a Polysubstance Use and Behavioral Health Intervention in New York City. Active
Principal Investigator, Big Data and the Opioid Overdose Epidemic: Algorithmic Ethics and Public Health Practice. Completed
Publications
Recent
Allen B, Schell RC, Jent VA, Krieger M, Pratty C, Hallowell BD, Goedel WC, Bastos M, Yedinak JL, Li Y, Cartus AR, Marshall BDL, Cerda M, Ahern J, Neill DB (2024).
PROVIDENT: Development and validation of a machine learning model to predict neighborhood-level overdose risk in Rhode Island
Epidemiology, 35 (2), 232-240. doi: 10.1097/EDE.0000000000001695. PMCID: PMC10842082.
PROVIDENT: Development and validation of a machine learning model to predict neighborhood-level overdose risk in Rhode Island
Epidemiology, 35 (2), 232-240. doi: 10.1097/EDE.0000000000001695. PMCID: PMC10842082.
Allen B, Neill DB, Schell RC, Ahern J, Hallowell BD, Krieger M, Jent VA, Goedel WC, Cartus AR, Yedinak JL, Pratty C, Marshall BDL, Cerda M (2023).
Translating predictive analytics for public health practice: A case study of overdose prevention in Rhode Island
American Journal of Epidemiology, 192 (10), 1659-1668. doi: 10.1093/aje/kwad119. PMCID: PMC10558193.
Translating predictive analytics for public health practice: A case study of overdose prevention in Rhode Island
American Journal of Epidemiology, 192 (10), 1659-1668. doi: 10.1093/aje/kwad119. PMCID: PMC10558193.
Allen B, Basaraba C, Corbeil T, Rivera BD, Levin FR, Martinez DM, Schultebraucks K, Henry BF, Pincus HA, Arout C, Krawczyk N (2023).
Racial differences in COVID-19 severity associated with history of substance use disorders and overdose: Findings from multi-site electronic health records in New York City
Preventive Medicine, 172, 107533. doi: 10.1016/j.ypmed.2023.107533. PMCID: PMC10155467.
Racial differences in COVID-19 severity associated with history of substance use disorders and overdose: Findings from multi-site electronic health records in New York City
Preventive Medicine, 172, 107533. doi: 10.1016/j.ypmed.2023.107533. PMCID: PMC10155467.
Cartus AR, Goedel WC, Jent VA, Macmadu A, Pratty C, Hallowell BD, Allen B, Li Y, Cerda M, Marshall BDL (2023).
Neighborhood-level association between release from incarceration and fatal overdose, Rhode Island, 2016-2020
Drug and Alcohol Dependence, 247, 109867. doi: 10.1016/j.drugalcdep.2023.109867. PMCID: PMC10198932.
Neighborhood-level association between release from incarceration and fatal overdose, Rhode Island, 2016-2020
Drug and Alcohol Dependence, 247, 109867. doi: 10.1016/j.drugalcdep.2023.109867. PMCID: PMC10198932.
Allen B, Urmanche A (2023).
NYC RxStat: Stakeholder perspectives on a national model public health and public safety partnership to reduce overdose deaths
Evaluation and Program Planning, 98, 102275. doi: 10.1016/j.evalprogplan.2023.102275.
NYC RxStat: Stakeholder perspectives on a national model public health and public safety partnership to reduce overdose deaths
Evaluation and Program Planning, 98, 102275. doi: 10.1016/j.evalprogplan.2023.102275.
Notable
Substance use stigma, primary care, and the New York State prescription drug monitoring program
Behavioral Medicine, 46 (1), 52-62. doi: 10.1080/08964289.2018.1555129.
Dr. Allen's Google Scholar Profile